COMMUNIQUÉS West-GlobeNewswire
-
Neuronetics Appoints Robert Greene as Senior Vice President Sales
02/06/2026 -
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2026 -
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2026 -
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
02/06/2026 -
Alvotech to present at upcoming investor conferences in June
02/06/2026 -
Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities
02/06/2026 -
L’ICSA rend hommage à l’honorable Don Boudria pour son engagement envers la santé animale
02/06/2026 -
Crescent Biopharma to Present at June Investor Conferences
02/06/2026 -
CAHI Honours The Honourable Don Boudria for Leadership in Animal Health
02/06/2026 -
Shopify Announces $3 Billion Increase to Share Repurchase Program
02/06/2026 -
Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026
02/06/2026 -
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02/06/2026 -
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
02/06/2026 -
Physicians Must Be Good Stewards of Their Practice, States the President of the Association of American Physicians and Surgeons (AAPS)
02/06/2026 -
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
02/06/2026 -
Alvotech to present at upcoming investor conferences in June
02/06/2026 -
Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026
02/06/2026 -
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2026 -
Onco360® Has Been Selected as a National Specialty Pharmacy Provider for IMKELDI® (imatinib) Oral Solution
02/06/2026
Pages